Evolva Holding SA announced that Emergent BioSolutions Inc. (NYSE: EBS) has acquired Evolva’s anti-bacterial programme, the EV-035 series. The lead ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE